Skip to main content
OpenTrials
Completed

NCT Number: NCT04991818

MSC - OneBiome UX Pilot Study

Evaluating the user (pregnant women and parents of young children) experience of the OneBiome consumers value journey service offered to the 1000 days and young children consumers market

Completed

Looking for future studies?

Notify Me

Key information

Age range

0 month and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

KK Women's and Children's Hospital, Singapore

Loading trial locations.

About this study

The OneBiome service aims to empower consumers with microbiome science in a friendly/consumer centric manner. The investigators wants to show that microbiome data can be used as an estimate of consumer's health and can be translated into actionable insights. The investigators aim to pilot a consumers' insight study to measure the perception/sentiments of this service in the Singapore market by recruiting study subjects from local public/private hospitals.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant women who are in the third trimester, or children from birth to 5 years of age
  • Pregnant women or parents of children should have access to the internet and a smartphone or tablet to access the OneBiome mobile friendly website.
  • Pregnant women or parents of children should be able to comprehend the content in the OneBiome mobile friendly website and complete the questionnaires in English.
  • Pregnant women and parents of children should stay in Singapore and remain contactable should they decide to do two microbiome assessments within 8 weeks

Exclusion criteria

  • Children born prematurely
  • Incapability of the pregnant women or parents of children to access OneBiome mobile friendly website and complete the questionnaires in English.
  • Any other family member is enrolled in the study
  • Incapability of the pregnant women or parents of children to comply with study protocol or Investigator's uncertainty about the willingness or ability of the pregnant women or parents of children to comply with the protocol requirements

Treatment and study plan

OneBiome microbiome profiling service

Other

participants will be asked to complete the user experience of the OneBiome service

Primary outcomes

  1. Overall user experience of the OneBiome microbiome profiling service

    Time frame: Approximately 8 weeks

    Pregnant women and parents of young children reported overall user experience of the OneBiome microbiome profiling service, i.e. average rating of the four following UX surveys1) overall experience of kit discovery (from unboxing to shipment); 2) ease of use of the stool collection kit; 3) overall user experience of the OneBiome web platform; 4) overall user experience of reading and understanding the microbiome analysis report.

Secondary outcomes

  1. User experience of different "steps/ phases" of the OneBiome consumers value journey service

    Time frame: Approximately 8 weeks

    Pregnant women and parents of young children reported user experience of different "steps/ phases" of the OneBiome consumers value journey service, including 'kit discovery, 'kit usage', 'web platform', 'evaluation of report', 'evaluation of service' and ''evaluation of consumer's motivation and consumption behaviour habits'

  2. Healthcare professional (HCP) reported overall experience of the OneBiome consumers value journey service

    Time frame: Approximately 8 weeks

    HCP reported overall user experience of the OneBiome microbiome profiling service

  3. HCP reported usefulness of microbiome data

    Time frame: Approximately 8 weeks

    HCP reported usefulness of microbiome data for their general practice based on user experience interaction between HCP and pregnant women and parents of young children

Other outcomes

  1. Microbiome composition of the participants

    Time frame: Approximately 8 weeks

    Microbiome composition in the stool sample of the subject which will be included in the microbiome analysis report to be shared with subject/ parent's subject.

  2. Association between microbiome composition and known factors that influence the microbiome

    Time frame: Approximately 8 weeks

    Association between microbiome composition and known factors that influence the microbiome in early life including mode of delivery, antibiotic prophylaxis, infant feeding patterns and diet.

  3. Food frequency questionnaire translation into food groups

    Time frame: Approximately 8 weeks

    FFQ data at the beginning and at the end of the study based on translation of FFQ into food groups according to the healthy plate guideline from the Health Promotion Board.

  4. Association between gut health parameters, stool images, microbiome composition and dietary patterns

    Time frame: Approximately 8 weeks

    Association between gut health parameters (symptoms, stool consistency, frequency and color, gastrointestinal infection, antibiotic intake) and stool images from participants, and microbiome composition and dietary patterns

Sponsors and collaborators

Lead sponsor

Danone Asia Pacific Holdings Pte, Ltd.

Industry

Collaborators

  • Chiang Children's Allergy and Asthma Clinic
  • KK Women's and Children's Hospital
  • The Child and Allergic Clinic

Registry information

Official study title

Evaluating the User Experience of the OneBiome Consumers Value Journey Service Offered to the 1000 Days and Young Children Consumers Market

Acronym: OneBiome

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Aug 5, 2021
Registry last updated
Jan 27, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.